| Literature DB >> 26978395 |
Huayi Suo1,2, Xin Zhao3,4,5, Yu Qian6,7,8, Peng Sun9,10,11, Kai Zhu12,13,14, Jian Li15, Baozhong Sun16.
Abstract
The purpose of the study was to determine the inhibitory effects of Lactobacillus fermentum Suo (LF-Suo) on HCl/ethanol induced gastric injury in ICR (Institute for Cancer Research) mice and explain the mechanism of these effects through the molecular biology activities of LF-Suo. The studied mice were divided into four groups: healthy, injured, LF-Suo-L and LF-Suo-H group. After the LF-Suo intragastric administration, the gastric injury area was reduced compared to the injured group. The serum MOT (motilin), SP (substance P), ET (endothelin) levels of LF-Suo treated mice were lower, and SS (somatostatin), VIP (vasoactive intestinal peptide) levels were higher than the injured group mice. The cytokine IL-6 (interleukin 6), IL-12 (interleukin 12), TNF-α (tumor necrosis factor-α) and IFN-γ (interferon-γ) serum levels were decreased after the LF-Suo treatment. The gastric tissues SOD (superoxide dismutase), GSH-Px (glutathione peroxidase), NO (nitric oxide) and activities of LF-Suo treated mice were increased and MDA (malondialdehyde) activity was decreased compared to the injured group mice. By the RT-PCR assay, LF-Suo raised the occludin, EGF (epidermal growth factor), EGFR (epidermal growth factor receptor), VEGF (vascular endothelial growth factor), Fit-1 (fms-like tyrosine kinase-1), IκB-α (inhibitor kappaB-α), nNOS (neuronal nitric oxide synthase), eNOS (endothelial nitric oxide synthase), Mn-SOD, Cu/Zn-SOD, CAT (catalase) mRNA or protein expressions and reduced the COX-2, NF-κB (nuclear factor kappaB), and iNOS (inducible nitric oxide synthase) expressions in gastric tissues compared to the gastric injured group mice. A high concentration (1.0 × 10⁸ CFU/kg b.w.) of LF-Suo treatment showed stronger anti-gastric injury effects compared to a low concentration of (0.5 × 10⁸ CFU/kg b.w.) of LF-Suo treatment. LF-Suo also showed strong survival in pH 3.0 man-made gastric juice and hydrophobic properties. These results indicate that LF-Suo has potential use as probiotics for its gastric injury treatment effects.Entities:
Keywords: Lactobacillus fermentum Suo; antioxidant; ethanol; gastric injury; mice
Mesh:
Substances:
Year: 2016 PMID: 26978395 PMCID: PMC4808883 DOI: 10.3390/nu8030155
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Sequences of reverse transcription-polymerase chain reaction primers used in this study.
| Gene Name | Sequence |
|---|---|
| Occludin | Forward: 5′-CTGTCTATGCTCGTCATCG-3′ |
| Reverse: 5′-CATTCCCGATCTAATGACGC-3′ | |
| COX-2 | Forward: 5′-TTA AAA TGA GAT TGT CCG AA-3′ |
| Reverse: 5′-AGA TCA CCT CTG CCT GAG TA-3′ | |
| EGF | Forward: 5′-GCC AAG CTC AGA AGG CTA C-3′ |
| Reverse: 5′-CAG GCC AGC CTC GTC TCA T-3′ | |
| EGFR | Forward: 5′-TCG GTG CTG TGC GAT TTA-3′ |
| Reverse: 5′-TTT CTG GCA GTT GCT CCT C-3′ | |
| VEGF | Forward: 5′-GCA CCC ATG GCA GAA GGA GGA G-3′ |
| Reverse: 5′-GTG CTG ACG CTA ACT GAC C-3′ | |
| Fit-1 | Forward: 5′-CAA GTG GCC AGA GGC ATG GAG TT-3′ |
| Reverse: 5′-GAT GTA GTC TTT ACC ATC CTG TTG-3′ | |
| NF-κB | Forward: 5′-CAC TTA TGG ACA ACT ATG AGG TCT CTG G-3′ |
| Reverse: 5′-CTG TCT TGT GGA CAA CGC AGT GGA ATT TTA GG-3′ | |
| IκB-α | Forward: 5′-GCT GAA GAA GGA GCG GCT ACT-3′ |
| Reverse: 5′-TCG TAC TCC TCG TCT TTC ATG GA-3′ | |
| nNOS | Forward: 5′-GAA TAC CAG CCT GAT CCA TGG AA-3′ |
| Reverse: 5′-TCC TCC AGG AGG GTG TCC ACC GCA TG-3′ | |
| eNOS | Forward: 5′-GGA GAG GCT GCA TGA CAT TG-3′ |
| Reverse: 5′-GGT AGA GCC ATA GTG GAA TGA C-3′ | |
| iNOS | Forward: 5′-AGA GAG ATC GGG TTC ACA-3′ |
| Reverse: 5′-CAC AGA ACT GAG GGT ACA-3′ | |
| Cu/Zn-SOD | Forward: 5′-GAAGAGAGGCATGTTGGAGA-3′ |
| Reverse: 5′-CCAATTACACCACGAGCCAA-3′ | |
| Mn-SOD | Forward: 5′-TTCAATAAGGAGCAGGGAC-3′ |
| Reverse: 5′-CAGTGTAAGGCTGACGGTTT-3′ | |
| CAT | Forward: 5′-AGATACTCCAAGGCGAAGGTG-3′ |
| Reverse: 5′-AAAGCCACGAGGGTCACGAAC-3′ | |
| GAPDH | Forward: 5′-CGG AGT CAA CGG ATT TGG TC-3′ |
| Reverse: 5′-AGC CTT CTC CAT GGT CGT GA-3′ |
Figure 1Stomachs of studied mice.
Stomach appearance of studied mice.
| Group | Gastric Injury | |
|---|---|---|
| Gastric Injury Area (mm2) 1 | Inhibitory Rate (%) 1 | |
| Healthy group | 0.0 ± 0.0 d | 100 ± 0.0 a |
| Injured group | 7.63 ± 0.41 a | 0.0 ± 0.0 d |
| LF-Suo-L group | 4.37 ± 0.24 b | 42.7 ± 2.8 c |
| LF-Suo-H group | 2.18 ± 0.26 c | 71.4 ± 3.1 b |
1 Values are mean ± SD. a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Gastric secretion volume and pH of studied mice.
| Group | Gastric Secretion Volume (mL) 1 | pH of the Gastric Juice 1 |
|---|---|---|
| Healthy group | 0.30 ± 0.02 d | 3.5 ± 0.1 a |
| Injured group | 1.39 ± 0.28 a | 1.1 ± 0.2 d |
| LF-Suo-L group | 0.88 ± 0.09 b | 2.3 ± 0.2 c |
| LF-Suo-H group | 0.51 ± 0.05 c | 2.9 ± 0.2 b |
1 Values are mean ± SD. a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Serum MOT, SP, SS, VIP and ET levels in studied mice.
| Group | MOT (μg/L) 1 | SP (μg/L) 1 | SS (μg/L) 1 | VIP (μg/L) 1 | ET (μg/L) 1 |
|---|---|---|---|---|---|
| Healthy group | 61.6 ± 4.7 d | 52.6 ± 3.8 d | 109.3 ± 7.3 a | 93.2 ± 6.2 a | 11.2 ± 0.5 d |
| Injured group | 141.7 ± 11.6 a | 116.2 ± 8.1 a | 60.7 ± 4.2 d | 54.1 ± 3.4 d | 20.3 ± 1.2 a |
| LF-Suo-L group | 106.3 ± 5.9 b | 86.8 ± 4.3 b | 77.6 ± 2.8 c | 67.0 ± 2.7 c | 17.5 ± 0.4 b |
| LF-Suo-H group | 84.5 ± 3.0 c | 72.6 ± 2.2 c | 89.3 ± 3.1 b | 74.3 ± 2.1 b | 15.2 ± 0.6 c |
1 Values are mean ± SD. a–e Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Cytokine IL-6, IL-12, TNF-α and IFN-γ levels of studied mice.
| Group | IL-6 (pg/mL) 1 | IL-12 (pg/mL) 1 | TNF-α (pg/mL) 1 | IFN-γ (pg/mL) 1 |
|---|---|---|---|---|
| Healthy group | 43.6 ± 2.4 d | 246.3 ± 31.9 d | 45.6 ± 2.6 d | 42.0 ± 2.2 d |
| Injured group | 128.7 ± 8.1 a | 877.9 ± 48.3 a | 141.2 ± 7.8 a | 93.6 ± 6.8 a |
| LF-Suo-L group | 88.6 ± 3.9 b | 522.8 ± 34.6 b | 87.3 ± 5.5 b | 79.4 ± 2.4 b |
| LF-Suo-H group | 65.3 ± 2.7 c | 461.7 ± 36.0 c | 70.1 ± 3.3 c | 63.9 ± 3.1 c |
1 Values are mean ± SD. a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Gastric tissues SOD, GSH-Px, NO and MDA activities of studied mice.
| Group | SOD (U/mgprot) 1 | GSH-Px (U/mgprot) 1 | NO (μmol/gprot) 1 | MDA (nmol/mgprot) 1 |
|---|---|---|---|---|
| Healthy group | 86.2 ± 5.2 a | 142.8 ± 3.7 a | 6.1 ± 0.4 a | 2.9 ± 0.2 e |
| Injured group | 47.6 ± 2.5 d | 108.3 ± 5.0 d | 1.7 ± 0.2 d | 6.7 ± 0.3 d |
| LF-Suo-L group | 55.8 ± 2.6 c | 120.8 ± 4.5 c | 3.2 ± 0.3 c | 4.5 ± 0.3 c |
| LF-Suo-H group | 68.1 ± 2.2 b | 129.7 ± 5.2 b | 4.8 ± 0.2 b | 3.9 ± 0.1 b |
1 Values are mean ± SD. a–e Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Figure 2Occludin, COX-2 mRNA (A) and protein (B) expression of studied mice. Fold-ratio: gene expression/GAPDH (β-actin) × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test.
Figure 3EGF and EGFR mRNA expression of studied mice. Fold-ratio: gene expression/GAPDH × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Figure 4VEGF, Fit-1 mRNA expression of studied mice. Fold-ratio: gene expression/GAPDH × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Figure 5NF-κB, IκB-α mRNA expression of studied mice. Fold-ratio: gene expression/GAPDH × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Figure 6nNOS, eNOS, iNOS mRNA (A) and protein (B) expression of studied mice. Fold-ratio: gene expression/GAPDH (β-actin) × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).
Figure 7Mn-SOD, Cu/Zn-SOD, CAT mRNA (A) and protein (B) expression of studied mice. Fold-ratio: gene expression/GAPDH (β-actin) × injured group numerical value (injured group fold ratio: 1). a–d Mean values with different letters in the same column are significantly different (p < 0.05) according to Duncan’s multiple-range test. LF-Suo-L, Lactobacillus fermentum Suo (0.5 × 109 CFU/kg b.w.); LF-Suo-H, Lactobacillus fermentum Suo (1.0 × 109 CFU/kg b.w.).